000291774 001__ 291774
000291774 005__ 20250514132633.0
000291774 0247_ $$2doi$$a10.1002/ctm2.1776
000291774 0247_ $$2pmid$$apmid:39032146
000291774 0247_ $$2pmc$$apmc:PMC11260171
000291774 037__ $$aDKFZ-2024-01510
000291774 041__ $$aEnglish
000291774 082__ $$a610
000291774 1001_ $$0P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1$$aJäger, Dirk$$b0$$eFirst author$$udkfz
000291774 245__ $$aNovel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.
000291774 260__ $$aHoboken, NJ$$bWiley$$c2024
000291774 3367_ $$2DRIVER$$aarticle
000291774 3367_ $$2DataCite$$aOutput Types/Journal article
000291774 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1721656455_17462$$xLetter
000291774 3367_ $$2BibTeX$$aARTICLE
000291774 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000291774 3367_ $$00$$2EndNote$$aJournal Article
000291774 500__ $$a#EA:D120#LA:D420#
000291774 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000291774 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000291774 650_7 $$2NLM Chemicals$$aReceptors, Chimeric Antigen
000291774 650_2 $$2MeSH$$aHumans
000291774 650_2 $$2MeSH$$aBreast Neoplasms: immunology
000291774 650_2 $$2MeSH$$aFemale
000291774 650_2 $$2MeSH$$aReceptors, Chimeric Antigen: therapeutic use
000291774 650_2 $$2MeSH$$aReceptors, Chimeric Antigen: immunology
000291774 650_2 $$2MeSH$$aTreatment Outcome
000291774 7001_ $$0P:(DE-He78)13dec090ab995ddbfa602b546eace8b0$$aBerger, Aileen$$b1$$eFirst author
000291774 7001_ $$0P:(DE-He78)5ab3e75a5a7c0a8d804f9833a1152067$$aTuch, Alexandra$$b2$$udkfz
000291774 7001_ $$aLuckner-Minden, Claudia$$b3
000291774 7001_ $$aEurich, Rosa$$b4
000291774 7001_ $$aHlevnjak, Mario$$b5
000291774 7001_ $$aSchneeweiss, Andreas$$b6
000291774 7001_ $$0P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aLichter, Peter$$b7$$udkfz
000291774 7001_ $$aAulmann, Sebastian$$b8
000291774 7001_ $$aHeussel, Claus-Peter$$b9
000291774 7001_ $$aFremd, Carlo$$b10
000291774 7001_ $$0P:(DE-He78)15dff5647002b4dcfe892b251cd14b62$$aHarbottle, Richard$$b11$$udkfz
000291774 7001_ $$aZörnig, Inka$$b12
000291774 7001_ $$0P:(DE-He78)0a9ff2c74a3fef06f552be5bb95bfd2d$$aSchmidt, Patrick$$b13$$eLast author$$udkfz
000291774 773__ $$0PERI:(DE-600)2697013-2$$a10.1002/ctm2.1776$$gVol. 14, no. 7, p. e1776$$n7$$pe1776$$tClinical and translational medicine$$v14$$x2001-1326$$y2024
000291774 8564_ $$uhttps://inrepo02.dkfz.de/record/291774/files/Clinical%20Translational%20Med%20-%202024%20-%20J%C3%A4ger%20-%20Novel%20chimeric%20antigen%20receptors%20for%20the%20effective%20and%20safe%20treatment%20of.pdf
000291774 8564_ $$uhttps://inrepo02.dkfz.de/record/291774/files/Clinical%20Translational%20Med%20-%202024%20-%20J%C3%A4ger%20-%20Novel%20chimeric%20antigen%20receptors%20for%20the%20effective%20and%20safe%20treatment%20of.pdf?subformat=pdfa$$xpdfa
000291774 909CO $$ooai:inrepo02.dkfz.de:291774$$pVDB
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13dec090ab995ddbfa602b546eace8b0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5ab3e75a5a7c0a8d804f9833a1152067$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)15dff5647002b4dcfe892b251cd14b62$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000291774 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a9ff2c74a3fef06f552be5bb95bfd2d$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000291774 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000291774 9141_ $$y2024
000291774 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN TRANSL MED : 2022$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-06-08T15:16:46Z
000291774 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-06-08T15:16:46Z
000291774 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2020-06-08T15:16:46Z
000291774 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-06-08T15:16:46Z
000291774 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCLIN TRANSL MED : 2022$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000291774 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000291774 9202_ $$0I:(DE-He78)D420-20160331$$kD420$$lDNA-Vektoren$$x0
000291774 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lD120 Angewandte Tumor-Immunität$$x0
000291774 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lB060 Molekulare Genetik$$x1
000291774 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000291774 9201_ $$0I:(DE-He78)D420-20160331$$kD420$$lDNA-Vektoren$$x3
000291774 9201_ $$0I:(DE-He78)D210-20160331$$kD210$$lGMP-Einheit Zelluläre Therapie$$x4
000291774 980__ $$ajournal
000291774 980__ $$aVDB
000291774 980__ $$aI:(DE-He78)D120-20160331
000291774 980__ $$aI:(DE-He78)B060-20160331
000291774 980__ $$aI:(DE-He78)HD01-20160331
000291774 980__ $$aI:(DE-He78)D420-20160331
000291774 980__ $$aI:(DE-He78)D210-20160331
000291774 980__ $$aUNRESTRICTED